Global Shingles Vaccine Market Research Report 2025(Status and Outlook)
Description
Report Overview
The shingles vaccine is a preventive immunization designed to protect against herpes zoster, a painful viral infection caused by the reactivation of the varicella-zoster virus (the same virus responsible for chickenpox). The vaccine works by boosting the immune system's ability to suppress viral reactivation, reducing the risk of developing shingles and its complications, such as postherpetic neuralgia (chronic nerve pain). Currently, two primary vaccines dominate the market: Zostavax (a live attenuated vaccine) and Shingrix (a recombinant subunit vaccine), with Shingrix being more widely recommended due to its higher efficacy and longer-lasting protection. The target demographic primarily includes adults aged 50 and older, as the risk of shingles increases with age, particularly among those with weakened immune systems. Rising awareness of shingles-related complications, increasing healthcare expenditure, and government vaccination programs in developed regions are key drivers of market growth. However, factors such as vaccine hesitancy, high costs, and limited accessibility in low-income regions may hinder adoption. The market is expected to expand further as aging populations grow globally and new advancements in vaccine technology emerge.
The global Shingles Vaccine market size was estimated at USD 1501.65 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Shingles Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Shingles Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Shingles Vaccine market.
Global Shingles Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
GlaxoSmithKline
Market Segmentation (by Type)
Zostavax
Shingrix
Market Segmentation (by Application)
Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Shingles Vaccine Market
Overview of the regional outlook of the Shingles Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Shingles Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Shingles Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The shingles vaccine is a preventive immunization designed to protect against herpes zoster, a painful viral infection caused by the reactivation of the varicella-zoster virus (the same virus responsible for chickenpox). The vaccine works by boosting the immune system's ability to suppress viral reactivation, reducing the risk of developing shingles and its complications, such as postherpetic neuralgia (chronic nerve pain). Currently, two primary vaccines dominate the market: Zostavax (a live attenuated vaccine) and Shingrix (a recombinant subunit vaccine), with Shingrix being more widely recommended due to its higher efficacy and longer-lasting protection. The target demographic primarily includes adults aged 50 and older, as the risk of shingles increases with age, particularly among those with weakened immune systems. Rising awareness of shingles-related complications, increasing healthcare expenditure, and government vaccination programs in developed regions are key drivers of market growth. However, factors such as vaccine hesitancy, high costs, and limited accessibility in low-income regions may hinder adoption. The market is expected to expand further as aging populations grow globally and new advancements in vaccine technology emerge.
The global Shingles Vaccine market size was estimated at USD 1501.65 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Shingles Vaccine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Shingles Vaccine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Shingles Vaccine market.
Global Shingles Vaccine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Merck
GlaxoSmithKline
Market Segmentation (by Type)
Zostavax
Shingrix
Market Segmentation (by Application)
Under 50 Years Old
50-60 Years Old
60-70 Years Old
Above 70 Years Old
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Shingles Vaccine Market
Overview of the regional outlook of the Shingles Vaccine Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Shingles Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Shingles Vaccine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
117 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Shingles Vaccine
- 1.2 Key Market Segments
- 1.2.1 Shingles Vaccine Segment by Type
- 1.2.2 Shingles Vaccine Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Shingles Vaccine Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Shingles Vaccine Market Size (M USD) Estimates and Forecasts (2020-2033)
- 2.1.2 Global Shingles Vaccine Sales Estimates and Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Shingles Vaccine Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Shingles Vaccine Product Life Cycle
- 3.3 Global Shingles Vaccine Sales by Manufacturers (2020-2025)
- 3.4 Global Shingles Vaccine Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Shingles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Shingles Vaccine Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Shingles Vaccine Market Competitive Situation and Trends
- 3.8.1 Shingles Vaccine Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Shingles Vaccine Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Shingles Vaccine Industry Chain Analysis
- 4.1 Shingles Vaccine Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Shingles Vaccine Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Shingles Vaccine Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Shingles Vaccine Market
- 5.7 ESG Ratings of Leading Companies
- 6 Shingles Vaccine Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Shingles Vaccine Sales Market Share by Type (2020-2025)
- 6.3 Global Shingles Vaccine Market Size Market Share by Type (2020-2025)
- 6.4 Global Shingles Vaccine Price by Type (2020-2025)
- 7 Shingles Vaccine Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Shingles Vaccine Market Sales by Application (2020-2025)
- 7.3 Global Shingles Vaccine Market Size (M USD) by Application (2020-2025)
- 7.4 Global Shingles Vaccine Sales Growth Rate by Application (2020-2025)
- 8 Shingles Vaccine Market Sales by Region
- 8.1 Global Shingles Vaccine Sales by Region
- 8.1.1 Global Shingles Vaccine Sales by Region
- 8.1.2 Global Shingles Vaccine Sales Market Share by Region
- 8.2 Global Shingles Vaccine Market Size by Region
- 8.2.1 Global Shingles Vaccine Market Size by Region
- 8.2.2 Global Shingles Vaccine Market Size Market Share by Region
- 8.3 North America
- 8.3.1 North America Shingles Vaccine Sales by Country
- 8.3.2 North America Shingles Vaccine Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Shingles Vaccine Sales by Country
- 8.4.2 Europe Shingles Vaccine Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Shingles Vaccine Sales by Region
- 8.5.2 Asia Pacific Shingles Vaccine Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Shingles Vaccine Sales by Country
- 8.6.2 South America Shingles Vaccine Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Shingles Vaccine Sales by Region
- 8.7.2 Middle East and Africa Shingles Vaccine Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Shingles Vaccine Market Production by Region
- 9.1 Global Production of Shingles Vaccine by Region(2020-2025)
- 9.2 Global Shingles Vaccine Revenue Market Share by Region (2020-2025)
- 9.3 Global Shingles Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Shingles Vaccine Production
- 9.4.1 North America Shingles Vaccine Production Growth Rate (2020-2025)
- 9.4.2 North America Shingles Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Shingles Vaccine Production
- 9.5.1 Europe Shingles Vaccine Production Growth Rate (2020-2025)
- 9.5.2 Europe Shingles Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Shingles Vaccine Production (2020-2025)
- 9.6.1 Japan Shingles Vaccine Production Growth Rate (2020-2025)
- 9.6.2 Japan Shingles Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Shingles Vaccine Production (2020-2025)
- 9.7.1 China Shingles Vaccine Production Growth Rate (2020-2025)
- 9.7.2 China Shingles Vaccine Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Merck
- 10.1.1 Merck Basic Information
- 10.1.2 Merck Shingles Vaccine Product Overview
- 10.1.3 Merck Shingles Vaccine Product Market Performance
- 10.1.4 Merck Business Overview
- 10.1.5 Merck SWOT Analysis
- 10.1.6 Merck Recent Developments
- 10.2 GlaxoSmithKline
- 10.2.1 GlaxoSmithKline Basic Information
- 10.2.2 GlaxoSmithKline Shingles Vaccine Product Overview
- 10.2.3 GlaxoSmithKline Shingles Vaccine Product Market Performance
- 10.2.4 GlaxoSmithKline Business Overview
- 10.2.5 GlaxoSmithKline SWOT Analysis
- 10.2.6 GlaxoSmithKline Recent Developments
- 11 Shingles Vaccine Market Forecast by Region
- 11.1 Global Shingles Vaccine Market Size Forecast
- 11.2 Global Shingles Vaccine Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Shingles Vaccine Market Size Forecast by Country
- 11.2.3 Asia Pacific Shingles Vaccine Market Size Forecast by Region
- 11.2.4 South America Shingles Vaccine Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Shingles Vaccine by Country
- 12 Forecast Market by Type and by Application (2026-2033)
- 12.1 Global Shingles Vaccine Market Forecast by Type (2026-2033)
- 12.1.1 Global Forecasted Sales of Shingles Vaccine by Type (2026-2033)
- 12.1.2 Global Shingles Vaccine Market Size Forecast by Type (2026-2033)
- 12.1.3 Global Forecasted Price of Shingles Vaccine by Type (2026-2033)
- 12.2 Global Shingles Vaccine Market Forecast by Application (2026-2033)
- 12.2.1 Global Shingles Vaccine Sales (K MT) Forecast by Application
- 12.2.2 Global Shingles Vaccine Market Size (M USD) Forecast by Application (2026-2033)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.